Biorep Technologies
Private Company
Total funding raised: $2M
Overview
Biorep Technologies is a specialized medical device CDMO with over 30 years of experience, offering integrated services from prototyping to commercial-scale manufacturing. The company's value proposition centers on deep domain expertise in regulated devices, a vertically integrated operational model, and flexible partnership structures that reduce vendor complexity for clients. Its ISO 13485-certified and FDA-registered infrastructure is designed to mitigate regulatory risk and streamline time-to-market for innovators in cardiovascular, surgical, ENT, and other therapeutic areas.
Technology Platform
Vertically integrated medical device CDMO platform encompassing rapid prototyping, design for manufacturability (DFM), process development, ISO 13485-certified contract manufacturing, and complex assembly services under a unified quality management system.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Biorep competes in a fragmented but competitive market of medical device contract manufacturers and CDMOs. Its primary differentiators are its exclusive focus on medical devices (not pharma), vertically integrated services, and over 30 years of specialized experience in navigating FDA and global regulatory pathways.